Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-16.6%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
-16.6%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025138.30%
2024-183.69%
202346.07%
2022-33.25%
202194.01%
2020342.27%
2019-34.15%
2018163.82%
201722.13%
2016-438.70%